Sintx Technologies (NASDAQ:SINT – Get Free Report) and Olympus (OTCMKTS:OCPNY – Get Free Report) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, valuation, risk and earnings.
Analyst Ratings
This is a breakdown of current ratings and target prices for Sintx Technologies and Olympus, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Sintx Technologies | 1 | 0 | 3 | 0 | 2.50 |
| Olympus | 0 | 0 | 1 | 0 | 3.00 |
Sintx Technologies currently has a consensus target price of $9.50, suggesting a potential upside of 445.98%. Given Sintx Technologies’ higher probable upside, analysts plainly believe Sintx Technologies is more favorable than Olympus.
Valuation & Earnings
This table compares Sintx Technologies and Olympus”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Sintx Technologies | $1.02 million | 7.37 | -$10.36 million | ($4.91) | -0.35 |
| Olympus | $7.74 billion | 2.99 | $1.03 billion | $0.82 | 21.95 |
Olympus has higher revenue and earnings than Sintx Technologies. Sintx Technologies is trading at a lower price-to-earnings ratio than Olympus, indicating that it is currently the more affordable of the two stocks.
Insider & Institutional Ownership
18.4% of Sintx Technologies shares are held by institutional investors. Comparatively, 0.0% of Olympus shares are held by institutional investors. 4.1% of Sintx Technologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Profitability
This table compares Sintx Technologies and Olympus’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Sintx Technologies | -848.20% | -354.44% | -115.37% |
| Olympus | 13.80% | 24.30% | 9.30% |
Summary
Olympus beats Sintx Technologies on 8 of the 13 factors compared between the two stocks.
About Sintx Technologies
Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyetheretherketone, and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.
About Olympus
Olympus Corp. engages in the manufacture and sale of precision machineries and instruments. It operates through the following segments: Medical, Scientific Solutions, Imaging, and Others. The Medical segment covers digestive, surgical, and ultrasonic endoscopy as well as endoscopic treatment tools. The Scientific Solutions segment manufactures and sells biological and industrial microscopes, industrial endoscopes, and non-destructive testing equipment. The Imaging segment deals with digital cameras and recording devices. The Others segment includes biomaterial manufacturing and sales business. The company was founded by Takeshi Yamashita on October 12, 1919 and is headquartered in Tokyo, Japan.
Receive News & Ratings for Sintx Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sintx Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
